EMVI-positive stage II rectal cancer has similar clinical outcomes as stage III disease following pre-operative chemoradiotherapy

Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer

(2013) M Chand et al.   BRITISH JOURNAL OF CANCER

mrEMVI status should be used in addition to pEMVI for treatment decision making in rectal cancer to prevent under-reporting of extramural venous invasion

(2013) Manish Chand et al.   EJSO

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

(2012) H. J. Schmoll et al.   ANNALS OF ONCOLOGY

Developments in the assessment of venous invasion in colorectal cancer: implications for future practice and patient outcome

(2012) David E. Messenger et al.   HUMAN PATHOLOGY

Preoperative High-resolution Magnetic Resonance Imaging Can Identify Good Prognosis Stage I, II, and III Rectal Cancer Best Managed by Surgery Alone

(2011) Fiona G.M Taylor et al.   ANNALS OF SURGERY

MRI Predictive Factors for Long-Term Outcomes of Low Rectal Tumours

(2011) Oliver C. Shihab et al.   ANNALS OF SURGICAL ONCOLOGY

Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials

(2010) K. Bujko et al.   ANNALS OF ONCOLOGY

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)

(2009) Vincenzo Valentini et al.   RADIOTHERAPY AND ONCOLOGY

MRI for Detection of Extramural Vascular Invasion in Rectal Cancer

(2008) Neil J. Smith et al.   AMERICAN JOURNAL OF ROENTGENOLOGY